Ultragenyx Pharmaceutical Inc
(FRA:UP0)
€
46.2
-0.4 (-0.86%)
Market Cap: 4.31 Bil
Enterprise Value: 3.76 Bil
PE Ratio: 0
PB Ratio: 13.42
GF Score: 81/100 Ultragenyx Pharmaceutical Inc at Jefferies London Healthcare Conference Transcript
Nov 17, 2022 / 10:25AM GMT
Release Date Price:
€34
(-0.58%)
Farzin Haque
Jefferies LLC, Research Division - Equity Associate
Hi, everyone. My name is Farzin Haque. I'm an associate from Morris team at Jefferies. It's a pleasure to welcome Emil Kakkis, CEO of Ultragenyx. I think he has a few slides to start off with.
Emil D. Kakkis
Ultragenyx Pharmaceutical Inc. - Founder, President, CEO & Director
Yes.
Farzin Haque
Jefferies LLC, Research Division - Equity Associate
Welcome.
Emil D. Kakkis
Ultragenyx Pharmaceutical Inc. - Founder, President, CEO & Director
Thank you for having me. It's good to be in London. It's been so long since I've been in London. Walking around Covent Garden, been a while, it's been in a long time, too long. Happy to be here in London again, one of my favorite places and talk to you a little about where Ultragenyx is.
12 years ago with me and my secretary, couple of million dollars, and this is where we are today. With the commercial franchise, there is a forward-looking statement,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot